Table 4
Standardised incidence ratios* (SIRs) for various cancers for employees with potential alachlor exposure (workplace or drinking water)
| Type of cancer | Any alachlor exposure | High alachlor exposure | 5+ years high exposure 15+ years since first exposure | ||||||
|---|---|---|---|---|---|---|---|---|---|
| O/E† | SIR | 95% CI | O/E† | SIR | 95% CI | O/E† | SIR | 95% CI | |
| *SIRs and 95% CIs were not calculated unless observed or expected cases exceeded 1. | |||||||||
| †Observed number of cases/expected number of cases. | |||||||||
| All cancers | 36/28.3 | 127 | 89 to 176 | 29/23.4 | 123 | 82 to 177 | 8/7.1 | 113 | 49 to 224 |
| Buccal cavity | 2/1.4 | 144 | 17 to 520 | 2/1.2 | 163 | 20 to 590 | 0/0.5 | ||
| Digestive | 8/5.6 | 142 | 61 to 279 | 6/4.9 | 122 | 45 to 265 | 2/1.9 | 108 | 13 to 389 |
| Colon | 4/2.4 | 169 | 46 to 434 | 4/2.1 | 194 | 53 to 497 | 2/0.8 | 256 | 31 to 925 |
| Rectum | 2/1.3 | 160 | 19 to 580 | 0/1.1 | 0 | 0 to 224 | 0/0.4 | ||
| Liver, gall bladder | 1/0.4 | 1/0.3 | 0/0.1 | ||||||
| Pancreas | 1/0.6 | 1/0.6 | 0/0.2 | ||||||
| Lung | 2/4.5 | 45 | 5 to 162 | 2/4.0 | 50 | 6 to 181 | 1/1.7 | 59 | 2 to 327 |
| Melanoma | 6/2.2 | 278 | 102 to 606 | 4/1.8 | 229 | 62 to 587 | 0/0.4 | ||
| Breast | 2/2.8 | 71 | 9 to 255 | 2/2.0 | 101 | 12 to 363 | 0/0.3 | ||
| Female genital | 2/1.5 | 136 | 17 to 492 | 1/1.0 | 0/0.2 | ||||
| Prostate | 4/3.5 | 115 | 31 to 295 | 4/3.2 | 125 | 34 to 319 | 2/1.7 | 120 | 15 to 434 |
| Testis | 3/1.3 | 235 | 49 to 686 | 1/1.0 | 0/0.1 | ||||
| Kidney | 1/1.1 | 94 | 2 to 526 | 1/0.9 | 1/0.4 | ||||
| Non-Hodgkin’s lymphoma | 3/1.7 | 173 | 36 to 504 | 3/1.5 | 207 | 43 to 604 | 1/0.5 | ||
| Hodgkin’s disease | 1/0.7 | 1/0.5 | 0/0.1 | ||||||
| Leukaemia | 2/1.1 | 176 | 21 to 636 | 2/1.0 | 206 | 25 to 744 | 0/0.3 | ||
| Chronic myeloid leukaemia | 2/0.2 | 955 | 116 to 3448 | 2/0.17 | 1165 | 141 to 4210 | 0/0.04 | ||
